Prevalence and phenotypic evaluation of Candida dubliniensis in pregnant women with vulvovaginal candidosis in a university hospital in Ankara

Mycoses

Volumn 50, Issue 1, 2007, Pages 13-20

  Us, E ^a   Cengiz, S A ^b  

^a ANKARA UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

Author keywords

Candida dubliniensis; Chlamydospores; Pregnant women; Staib agar; Vulvovaginal candidosis

Indexed keywords

AGAR; POLYSORBATE 80;

ARTICLE; CANDIDA DUBLINIENSIS; CONTROLLED STUDY; FEMALE; FUNGAL MORPHOLOGY; FUNGAL STRAIN; FUNGUS GROWTH; FUNGUS ISOLATION; HUMAN; MAJOR CLINICAL STUDY; MICROBIOLOGICAL EXAMINATION; NONHUMAN; PHENOTYPE; PREGNANT WOMAN; PREVALENCE; PRIORITY JOURNAL; UNIVERSITY HOSPITAL; VAGINA CANDIDIASIS; VAGINA DISCHARGE;

AGAR; CANDIDA; CANDIDIASIS, VULVOVAGINAL; CULTURE MEDIA; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; MYCOLOGICAL TYPING TECHNIQUES; PHENOTYPE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; SPORES, FUNGAL; TURKEY;

CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS;

EID: 33846029118     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2006.01289.x     Document Type: Article

References (36)

1. Sullivan DJ, Moran G, Donnelly S et al. Candida dubliniensis: an update. Rev Iberoam Micol 1999; 16: 72-76.
2. Gilfillan GD, Sullivan DJ, Haynes K, Parkinson T, Coleman DC, Gow NA. Candida dubliniensis: phylogeny and putative virulence factors. Microbiology 1998; 144: 829-38.
3. Sullivan DJ, Westerneng TJ, Haynes KA, Bennett DE, Coleman DC. Candida dubliniensis sp. nov: phenotypic and molecular characterization of novel species associated with oral candidosis in HIV infected individuals. Microbiology 1995; 141: 1507-21.
4. Pincus DH, Coleman DC, Pruitt WR et al. Rapid identification of Candida dubliniensis with commercial yeast identification systems. J Clin Microbiol 1999; 37: 3533-9.
5. Odds FC, Nuffel LV, Dams G. Prevalence of Candida dubliniensis isolates in a yeast stock collection. J Clin Microbiol 1998; 36: 2869-73.
6. Moran GP, Sanglard D, Donnelly SM, Shanley DB, Sullivan DJ, Coleman DC. Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis. Antimicrob Agents Chemother 1998; 42: 1819-30.
7. Moran GP, Sullivan DJ, Henman MC et al. Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV- infected subjects and generation of stable fluconazole-resistant derivatives in vitro. Antimicrob Agents Chemother 1997; 41: 617-23.
8. Sullivan D, Haynes K, Bille J et al. Widespread geographic distribution of oral Candida dubliniensis strains in human immunodeficiency virus-infected individuals. J Clin Microbiol 1997; 35: 960-4.
9. Jabra-Rizk MA, Falkler WA, Merz WG, Baqui AA, Kelley JI, Meiller TF. Retrospective identification and characterization of Candida dubliniensis isolates among Candida albicans clinical laboratory isolates from human immunodeficiency virus (HIV)-infected and non- HIV-infected individuals. J Clin Microbiol 2000; 38: 2423-6.
10. Pfaller MA, Messer SA, Gee S et al. In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents. J Clin Microbiol 1999; 37: 870-2.
11. Jabra-Rizk MA, Baqui AA, Kelley JI, Falkler WA, Merz WG, Meiller TF. Identification of Candida dubliniensis in a prospective study of patients in the United States. J Clin Microbiol 1999; 37: 321-6.
12. Meis JF, Ruhnke M, De Pauw BE, Odds FC, Siegert W, Verweij PE. Candida dubliniensis candidemia in patients with chemotherapy-induced neutropenia and bone marrow transplantation. Emerg Infect Dis 1999; 5: 150-3.
13. Sullivan D, Coleman D. Candida dubliniensis: characteristics and identification. J Clin Microbiol 1998; 36: 329-34.
14. Sullivan DJ, Moran GP, Pinjon E et al. Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans. FEMS Yeast Res 2004; 4: 369-76.
15. Marriott D, Laxton M, Harkness J. Candida dubliniensis candidemia in Australia. Emerg Infect Dis 2001; 7: 479.
16. Raghupathy R. Th1-type immunity is incompatible with successful pregnancy. Immunol Today 1997; 18: 478-82.
17. Xu J, Sobel JD. Candida vulvovaginitis in pregnancy. Curr Infect Dis Rep 2004; 6: 445-9.
18. Vidotto V, Mantoan B, Pugliese A et al. Adherence of Candida albicans and Candida dubliniensis to buccal and vaginal cells. Rev Iberoam Micol 2003; 20: 52-54.
19. Kurzai O, Heinz WJ, Sullivan DJ, Coleman DC, Frosch M, Muhlschlegel FA. Rapid PCR test for discriminating between Candida albicans and Candida dubliniensis isolates using primers derived from the pH-regulated PHR1 and PHR2 genes of C. albicans. J Clin Microbiol 1999; 37: 1587-90.
20. Staib P, Morschhauser J. Chlamydospore formation on Staib agar as a species-specific characteristic of Candida dubliniensis. Mycoses 1999; 42: 521-4.
21. Kirkpatrick WR, Revankar SG, Mcatee RK et al. Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar Candida screening and susceptibility testing of isolates. J Clin Microbiol 1998; 36: 3007-12.
22. Salkin IF, Pruitt WR, Padhye AA, Sullivan D, Coleman D, Pincus DH. Distinctive carbohydrate assimilation profiles used to identify the first clinical isolates of Candida dubliniensis recovered in the United States. J Clin Microbiol 1998; 36: 1467.
23. Coleman DC, Rinaldi MG, Haynes KA et al. Importance of Candida species other than Candida albicans as opportunistic pathogens. Med Mycol 1998; 36: 156-65.
24. Ponton J, Ruchel R, Clemons KV et al. Emerging pathogens. Med Mycol 2000; 38: 225-36.
25. Cimolai N, Davis J, Trombley C. Candida dubliniensis fungemia and vascular access infection. J Pediatr Hematol Oncol 2002; 24: 237-9.
26. Weinberg ED. Pregnancy-associated depression of cell-mediated immunity. Rev Infect Dis 1984; 6: 814-31.
27. Boris S, Suarez JE, Vasquez F, Barbes C. Adherence of human vaginal lactobacilli to vaginal epithelial cells and interaction with uropathogens. Infect Immun 1998; 66: 1985-9.
28. Coleman DC, Sullivan DJ, Bennet DE, Moran GP, Barry HJ, Shanley DB. Candidiasis: the emergence of a novel species, Candida dubliniensis. AIDS 1997; 11: 557-67.
29. Acikgoz ZC, Sancak B, Gamberzade S, Misirlioǧlu M. Prevalence of Candida dubliniensis among the stored vaginal Candida isolates in a Turkish hospital. Mycoses 2004; 47: 393-6.
30. Al-Sweih N, Ahmad S, Khan ZU, Khan S, Chandy R. Prevalence of Candida dubliniensis among germ tube-positive Candida isolates in a maternity hospital in Kuwait. Mycoses 2005; 48: 347-51.
31. Fotedar R, Al-Hedaithy SS. Candida dubliniensis at a university hospital in Saudi Arabia. J Clin Microbiol 2003; 41: 1907-11.
32. Mahnss B, Stehr F, Schafer W, Neuber K. Comparison of standard phenotypic assays with a PCR method to discriminate Candida albicans and C. dubliniensis. Mycoses 2005; 48: 55-61.
33. Schoofs A, Odds FC, Colebunders R, Ieven M, Goossens H. Use of specialised isolation media for recognition and identification of Candida dubliniensis isolates from HIV-infected patients. Eur J Clin Microbiol Infect Dis 1997; 16: 296-300.
34. Tintelnot K, Haase G, Seibold M et al. Evaluation of phenotypic markers for selection and identification of Candida dubliniensis. J Clin Microbiol 2000; 38: 1599-608.
35. Gales AC, Pfaller MA, Houston AK et al. Identification of Candida dubliniensis based on temperature and utilization of xylose and α-methyl-D-glucoside as determined with the API 20C AUX and Vitek YBC stystems. J Clin Microbiol 1999; 37: 3804-8.
36. Al Mosaid A, Sullivan D, Salkin IF, Shanley D, Coleman DC. Differentiation of Candida dubliniensis from Candida albicans on Staib agar and caffeic acid-ferric citrate agar. J Clin Microbiol 2001; 39: 323-7.